Government-Owned Inventions; Availability for Licensing, 48630 [2019-19951]

Download as PDF 48630 Federal Register / Vol. 84, No. 179 / Monday, September 16, 2019 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: September 10, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–19944 Filed 9–13–19; 8:45 am] BILLING CODE 4140–01–P SUPPLEMENTARY INFORMATION: Technology description follows. DEPARTMENT OF HEALTH AND HUMAN SERVICES PET Imaging of fungal infections National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, November 8, 2019, 8:30 a.m. to 5:00 p.m., National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20817 which was published in the Federal Register on February 11, 2019, 84 FR 3205. The meeting notice is amended to change the Contact Person from Dr. Richard A. Rippe to Dr. Beata Buzas. Dr. Buzas may be reached at National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B Rockledge Drive, Room 2116, Rockville, MD 20852, 301–443– 0800, bbuzas@mail.nih.gov. The meeting is closed to the public. Dated: September 10, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–19945 Filed 9–13–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. to achieve expeditious commercialization of results of federally-funded research and development. FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained jspears on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:14 Sep 13, 2019 Jkt 247001 by emailing the indicated licensing contact at the National Heart, Lung, and Blood, Office of Technology Transfer and Development Office of Technology Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892–2479; telephone: 301–402–5579. A signed Confidential Disclosure Agreement may be required to receive any unpublished information. Available for licensing and commercial development are patent rights covering a PET imaging method for fungal infections, for example, Aspergillus fumigatus. Currently, there is a lack of imaging agents specific for fungal infections. L-Rhamnose is selectively uptaken by live A. fumigatus. PET imaging experiments showed a 39% increase in uptake by infected mice as opposed to control mice when administered 18Fdeoxyrhamnose. As such, the instant imaging agent has potential as a fungal infection diagnostic imaging agent. Potential Commercial Applications: • Imaging of live fungal infections • Imaging of live infections of A. fumigatus Development Stage: • Preclinical • Mouse data Inventors: Dima Hammoud (NIHCC), Rolf Swenson (NHLBI), Xiang (Sean) Zhang (NHLBI), Swati Shah (CC) and Peter Richard Williamson (NIAID). Intellectual Property: HHS Reference No. E–163–2019–0–US–01 ; U.S Patent Applications 62/882,023 filed August 2, 2019; Klarquist Ref. No. 4239–103017– 01. Licensing Contact: Michael Shmilovich, Esq, CLP; 301–435–5019; shmilovm@mail.nih.gov. Dated: September 3, 2019. Michael A. Shmilovich, Senior Licensing and Patenting Manager, National Heart, Lung, and Blood Institute, Office of Technology Transfer and Development. [FR Doc. 2019–19951 Filed 9–13–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Accreditation and Approval of AmSpec LLC (Christiansted, St. Croix, USVI) as a Commercial Gauger and Laboratory U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of accreditation and approval of AmSpec LLC (Christiansted, St. Croix, USVI), as a commercial gauger and laboratory. AGENCY: Notice is hereby given, pursuant to CBP regulations, that AmSpec LLC (Christiansted, St. Croix, USVI), has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes for the next three years as of June 5, 2019. DATES: AmSpec LLC (Christiansted, St. Croix, USVI) was approved and accredited as a commercial gauger and laboratory as of June 5, 2019. The next triennial inspection date will be scheduled for June 2022. FOR FURTHER INFORMATION CONTACT: Dr. Eugene Bondoc, Laboratories and Scientific Services, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW, Suite 1500N, Washington, DC 20229, tel. 202–344–1060. SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to 19 CFR 151.12 and 19 CFR 151.13, that AmSpec LLC, 9010 East Cottage, Suite 3, Christiansted, St. Croix, USVI 00820, has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. AmSpec LLC (Christiansted, St. Croix, USVI) is approved for the following gauging procedures for petroleum and certain petroleum products from the American Petroleum Institute (API): SUMMARY: API chapters 1 ................... 3 ................... 7 ................... 8 ................... 11 ................. 12 ................. 17 ................. Title Vocabulary. Tank Gauging. Temperature Determination. Sampling. Physical Properties Data. Calculations. Maritime Measurement. AmSpec LLC (Christiansted, St. Croix, USVI) is accredited for the following laboratory analysis procedures and methods for petroleum and certain Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\16SEN1.SGM 16SEN1

Agencies

[Federal Register Volume 84, Number 179 (Monday, September 16, 2019)]
[Notices]
[Page 48630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19951]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. to achieve 
expeditious commercialization of results of federally-funded research 
and development.

FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained 
by emailing the indicated licensing contact at the National Heart, 
Lung, and Blood, Office of Technology Transfer and Development Office 
of Technology Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, 
MD 20892-2479; telephone: 301-402-5579. A signed Confidential 
Disclosure Agreement may be required to receive any unpublished 
information.

SUPPLEMENTARY INFORMATION: Technology description follows.

PET Imaging of fungal infections

    Available for licensing and commercial development are patent 
rights covering a PET imaging method for fungal infections, for 
example, Aspergillus fumigatus. Currently, there is a lack of imaging 
agents specific for fungal infections. L-Rhamnose is selectively 
uptaken by live A. fumigatus. PET imaging experiments showed a 39% 
increase in uptake by infected mice as opposed to control mice when 
administered 18F-deoxyrhamnose. As such, the instant imaging agent has 
potential as a fungal infection diagnostic imaging agent.
    Potential Commercial Applications:

 Imaging of live fungal infections
 Imaging of live infections of A. fumigatus

    Development Stage:

 Preclinical
 Mouse data
    Inventors: Dima Hammoud (NIHCC), Rolf Swenson (NHLBI), Xiang (Sean) 
Zhang (NHLBI), Swati Shah (CC) and Peter Richard Williamson (NIAID).
    Intellectual Property: HHS Reference No. E-163-2019-0-US-01 ; U.S 
Patent Applications 62/882,023 filed August 2, 2019; Klarquist Ref. No. 
4239-103017-01.
    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
[email protected].

    Dated: September 3, 2019.
Michael A. Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2019-19951 Filed 9-13-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.